Clinical pharmacology of the antibody-drug conjugate enfortumab vedotin in advanced urothelial carcinoma and other malignant solid tumors Meeting Abstract


Authors: Tang, M.; Garg, A.; Bonate, P.; Rosenberg, J. E.; Kadokura, T.; Yamada, A.; Fukushi, R.; Koibuchi, A.; Hanley, W. D.; Poondru, S.
Abstract Title: Clinical pharmacology of the antibody-drug conjugate enfortumab vedotin in advanced urothelial carcinoma and other malignant solid tumors
Meeting Title: 2022 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 6 Suppl.
Meeting Dates: 2022 Feb 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-02-20
Language: English
ACCESSION: WOS:000771008900575
DOI: 10.1200/JCO.2022.40.6_suppl.568
PROVIDER: wos
Notes: Meeting Abstract: 568 -- Meeting was conducted online as well as in person -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg